Decoy Therapeutics, Inc. (DCOY)
1.23
+0.13
(+11.82%)
USD |
NASDAQ |
Oct 29, 16:00
1.21
-0.02
(-1.63%)
Pre-Market: 08:48
Decoy Therapeutics Price to Book Value : 0.1514 for Oct. 29, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 0.1514 |
| October 28, 2026 | 0.1354 |
| October 27, 2026 | 0.1268 |
| October 26, 2026 | 0.1133 |
| October 23, 2026 | 0.1194 |
| October 22, 2026 | 0.1268 |
| October 21, 2026 | 0.1317 |
| October 20, 2026 | 0.1397 |
| October 19, 2026 | 0.1441 |
| October 16, 2026 | 0.1441 |
| October 15, 2026 | 0.1514 |
| October 14, 2026 | 0.1441 |
| October 13, 2026 | 0.1527 |
| October 12, 2026 | 0.1761 |
| October 09, 2026 | 0.181 |
| October 08, 2026 | 0.1871 |
| October 07, 2026 | 0.1982 |
| October 06, 2026 | 0.1908 |
| October 05, 2026 | 0.2056 |
| October 02, 2026 | 0.2179 |
| October 01, 2026 | 0.2284 |
| September 30, 2026 | 0.2426 |
| September 29, 2026 | 0.2623 |
| September 28, 2026 | 0.2844 |
| September 25, 2026 | 0.3804 |
| Date | Value |
|---|---|
| September 24, 2026 | 0.3829 |
| September 23, 2026 | 0.474 |
| September 22, 2026 | 0.3817 |
| September 21, 2026 | 0.3152 |
| September 18, 2026 | 0.3423 |
| September 17, 2026 | 0.3484 |
| September 16, 2026 | 0.3558 |
| September 15, 2026 | 0.3337 |
| September 14, 2026 | 0.3337 |
| September 11, 2026 | 0.3287 |
| September 10, 2026 | 0.3361 |
| September 09, 2026 | 0.3398 |
| September 08, 2026 | 0.3238 |
| September 04, 2026 | 0.3312 |
| September 03, 2026 | 0.3546 |
| September 02, 2026 | 0.3669 |
| September 01, 2026 | 0.3768 |
| August 31, 2026 | 0.3755 |
| August 28, 2026 | 0.3571 |
| August 27, 2026 | 0.3657 |
| August 26, 2026 | 0.3706 |
| August 25, 2026 | 0.3669 |
| August 24, 2026 | 0.3829 |
| August 21, 2026 | 0.394 |
| August 20, 2026 | 0.4038 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.735 |
| Alnylam Pharmaceuticals, Inc. | 6.464 |
| Anika Therapeutics, Inc. | 2.124 |
| Savara, Inc. | 7.077 |
| Vericel Corp. | 5.934 |
Price to Book Value Related Metrics
| PS Ratio | 2.210 |
| Price | 1.23 |
| Earnings Yield | -3.84K% |
| Market Cap | 0.6544M |